Medigen Vaccine Biologics (ROCO:6547) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6547 Medigen Vaccine Biologics Corp ROCO:6547
69 GF Score
Price NT$45.70
GF Value NT$57.74
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medigen Vaccine Biologics FFO per Share?

FFO per Share only applies to REITs.

ROCO:6547
69GF Score
Medigen Vaccine Biologics Corp ROCO:6547
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medigen Vaccine Biologics (ROCO:6547) Overvalued in 2026?

Based on GuruFocus' analysis, Medigen Vaccine Biologics stock appears to be undervalued. The current stock price of NT$45.70 is trading 20.9% below its estimated GF Value™ of NT$57.74. GuruFocus considers Medigen Vaccine Biologics to be Modestly Undervalued.

Key valuation signals for ROCO:6547:

  • FFO per Share:
  • GF Value™: NT$57.74 vs. price of NT$45.70 (20.9% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medigen Vaccine Biologics Business Description

Address 302 No. 68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is engaged in the research, development and wholesale of vaccine and biopharmaceutical, medical devices wholesale and retail, etc. Its products include dengue vaccine, anti-RSV biosimilars, COVID-19 vaccines, enterovirus A71 vaccine, and influenza vaccine QIZ. It operates business only in a single industry in Taiwan.
69GF Score

Get the complete analysis for ROCO:6547

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.70
Price
NT$57.74
GF Value